Financial
Latest full-year results from official filings.
Part of RadNet (RDNT).
Latest full-year results not yet captured by HSH.
iCAD: risk summary
Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.
Researched 8 Nov 2026
Adverse media
Credible news about incidents, disputes, legal action or restructuring in the last 24 months.
Aug 2025: RadNet's subsidiary DeepHealth completed its acquisition of iCAD, folding iCAD's business, technology and regulatory functions into DeepHealth; buyers should note the change of ownership.
- RadNet's DeepHealth completes acquisition of AI breast health company iCAD · FemTech Insider · 7 Aug 2025
Cyber & information governance
Data breaches, cyber incidents, regulator action and assurance status.
No data breaches, cyber incidents or regulator action involving iCAD found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Regulatory & clinical safety
Recalls, safety notices, regulator action and clinical safety concerns.
No recalls, FDA/MHRA safety notices or warning letters involving iCAD or its ProFound AI products found in HSH's search of the last 24 months.
Contract performance
Contract delivery, go-lives, terminations and disputes.
No notable go-lives, troubled implementations, terminations or significant NHS contracts involving iCAD found in HSH's search of the last 24 months.